We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTR
451
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $16.3M | 0.04% |
324,691
-188,688
| -37% | -$9.28M |
|
|
HIBB
452
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $16.3M | 0.04% |
581,789
+194,013
| +50% | +$4.92M |
|
453
Rambus
RMBS
$11B
| $16.3M | 0.04% |
1,182,170
+861,062
| +268% | +$11.6M |
|
454
Belden
BDC
$5.19B
| $16.1M | 0.04% |
293,522
+68,487
| +30% | +$3.66M |
|
455
Kforce
KFRC
$1.06B
| $16.1M | 0.04% |
405,233
+187,983
| +87% | +$7.43M |
|
456
Simmons First National
SFNC
$3.39B
| $16.1M | 0.04% |
599,850
-26,187
| -4% | -$661K |
|
457
TD Synnex
SNX
$20.2B
| $16.1M | 0.04% |
+249,276
| New | +$15M |
|
|
NS
458
DELISTED
NuStar Energy L.P.
NS
| $16M | 0.04% |
+619,351
| New | +$17.2M |
|
|
AVYA
459
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $16M | 0.04% |
+1,182,978
| New | +$14.5M |
|
460
Teladoc Health
TDOC
$1.3B
| $15.9M | 0.04% |
+190,489
| New | +$14.5M |
|
461
Allstate
ALL
$67.5B
| $15.9M | 0.04% |
141,768
+135,768
| +2,263% | +$14.8M |
|
462
O-I Glass
OI
$1.08B
| $15.9M | 0.04% |
1,332,061
+165,900
| +14% | +$1.66M |
|
|
SYKE
463
DELISTED
SYKES Enterprises Inc
SYKE
| $15.9M | 0.04% |
428,966
+45,500
| +12% | +$1.54M |
|
|
ZNGA
464
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $15.7M | 0.04% |
+2,559,264
| New | +$15.8M |
|
465
Walker & Dunlop
WD
$1.53B
| $15.6M | 0.04% |
241,356
+85,101
| +54% | +$5.38M |
|
466
Pathward Financial
CASH
$1.8B
| $15.6M | 0.04% |
426,343
+372,543
| +692% | +$12.7M |
|
467
Columbia Sportswear
COLM
$2.94B
| $15.6M | 0.04% |
155,316
-346,209
| -69% | -$32.9M |
|
|
MIK
468
DELISTED
Michaels Stores, Inc
MIK
| $15.5M | 0.04% |
1,920,948
-460,831
| -19% | -$3.87M |
|
469
PetMed Express
PETS
$42.3M
| $15.5M | 0.04% |
658,909
+602,935
| +1,077% | +$13.5M |
|
470
Eli Lilly
LLY
$1.06T
| $15.4M | 0.04% |
117,397
-1,074,974
| -90% | -$125M |
|
|
NAV
471
DELISTED
Navistar International
NAV
| $15.4M | 0.04% |
530,885
+185,436
| +54% | +$5.7M |
|
472
Acco Brands
ACCO
$407M
| $15.3M | 0.04% |
1,638,129
+717,777
| +78% | +$6.8M |
|
473
Yeti Holdings
YETI
$3.95B
| $15.3M | 0.04% |
438,568
+229,349
| +110% | +$7.23M |
|
474
Honda
HMC
$41.3B
| $15.2M | 0.04% |
537,246
+277,784
| +107% | +$7.74M |
|
475
Melco Resorts & Entertainment
MLCO
$2.14B
| $15.2M | 0.04% |
627,174
+178,847
| +40% | +$3.89M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.